Good Growth Capital

Good Growth Capital is a venture firm with a thesis focused on early-stage science and technology investing, particularly in deep tech, life sciences, and frontier technology businesses with strong technical defensibility. The goodgrowthvc.com website confirms an active investor with attention to scientific founders and rigorous technical diligence. For healthcare AI founders, Good Growth is a credible match for science-led businesses: AI for drug discovery, computational biology, novel medical imaging architectures, foundation models for biology, and life sciences tools with strong technical edge. Founders building digital health workflow SaaS, telehealth services, or healthcare-flavored consumer apps should look elsewhere; this is a deep tech investor with a science orientation, not a vertical SaaS investor. Plausible check sizes run 500K to 2M at seed and early Series A, with selective follow-on. The firm leads or co-leads in science-led rounds. Entry path is warm introduction through scientific operators, university research networks, or other deep tech investors in their syndicate networks. LinkedIn outreach to partners with a technically substantive opening can also work for credible scientific founders. The firm reads inbound and engages with credible technical pitches. Diligence will be technically rigorous: expect engagement with your scientific co-founders, scrutiny of publications and IP, regulatory strategy assessment for medical applications, and competitive analysis against academic and industrial labs. Bring your technical lead and scientific advisors. Good Growth rewards founders who can defend the underlying science and articulate why their approach is durable; do not pitch market size and growth metrics first. The value-add includes scientific network access, technical advisory support, and credibility with downstream specialist investors.